<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>News Article and Medical Journal &#187; Internal Medicine</title>
	<atom:link href="http://d02now.com/category/internal/feed/" rel="self" type="application/rss+xml" />
	<link>http://d02now.com</link>
	<description></description>
	<lastBuildDate>Tue, 07 Dec 2010 17:40:30 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>Impaired Renal Function Pathophysiology in Dyslipidemia</title>
		<link>http://d02now.com/internal/impaired-renal-function-pathophysiology-in-dyslipidemia.html</link>
		<comments>http://d02now.com/internal/impaired-renal-function-pathophysiology-in-dyslipidemia.html#comments</comments>
		<pubDate>Tue, 07 Dec 2010 17:40:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Dyslipidemia]]></category>
		<category><![CDATA[Impaired Renal]]></category>
		<category><![CDATA[Lipid Lowering Therapy]]></category>
		<category><![CDATA[pathophysiology]]></category>

		<guid isPermaLink="false">http://d02now.com/internal/impaired-renal-function-pathophysiology-in-dyslipidemia.html</guid>
		<description><![CDATA[The following article describes Impaired Renal Function Pathophysiology and Lipid Lowering Therapy in conjunction with  dyslipidemia and renal disease. It summarizes the abnormalities in lipid metabolism associated with renal disease as well as therapeutic procedures for lipid lowering in patients with impaired renal function.]]></description>
		<wfw:commentRss>http://d02now.com/internal/impaired-renal-function-pathophysiology-in-dyslipidemia.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Insulin Therapy Initiation Algorithm Guide for Type II Diabetes</title>
		<link>http://d02now.com/internal/dm/insulin-therapy-initiation-algorithm-guide-for-type-ii-diabetes.html</link>
		<comments>http://d02now.com/internal/dm/insulin-therapy-initiation-algorithm-guide-for-type-ii-diabetes.html#comments</comments>
		<pubDate>Tue, 09 Mar 2010 03:18:01 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[DM]]></category>
		<category><![CDATA[insulin therapy]]></category>
		<category><![CDATA[insulin therapy guidelines]]></category>
		<category><![CDATA[type II diabetes]]></category>

		<guid isPermaLink="false">http://d02now.com/internal/dm/insulin-therapy-initiation-algorithm-guide-for-type-ii-diabetes.html</guid>
		<description><![CDATA[The following algorithm diagram shows a simplified approach of Insulin Therapy Initiation for Type II Diabetes Mellitus.]]></description>
		<wfw:commentRss>http://d02now.com/internal/dm/insulin-therapy-initiation-algorithm-guide-for-type-ii-diabetes.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Influenza A (H1N1) Vaccine Risk-Benefit Monitoring in Europe</title>
		<link>http://d02now.com/internal/animal-born-disease/swine-flu/influenza-a-h1n1-vaccine-risk-benefit-monitoring-in-europe.html</link>
		<comments>http://d02now.com/internal/animal-born-disease/swine-flu/influenza-a-h1n1-vaccine-risk-benefit-monitoring-in-europe.html#comments</comments>
		<pubDate>Mon, 30 Nov 2009 02:30:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Swine Flu]]></category>
		<category><![CDATA[Vaccine]]></category>
		<category><![CDATA[H1N1 Vaccine Europe]]></category>
		<category><![CDATA[vaccine monitoring strategy]]></category>

		<guid isPermaLink="false">http://d02now.com/internal/animal-born-disease/swine-flu/influenza-a-h1n1-vaccine-risk-benefit-monitoring-in-europe.html</guid>
		<description><![CDATA[The document covers materials such as Influenza A (H1N1) vaccines safety and effectiveness, the immunogenicity, benefit-risk evaluation, vaccine manufacturers, the vaccines authorised, research, clinical and public health centres, components of strategies in monitoring the benefit-risk  A/H1N1 vaccines, and the funding mechanisms in relation to the overall benefit-risk assesment.]]></description>
		<wfw:commentRss>http://d02now.com/internal/animal-born-disease/swine-flu/influenza-a-h1n1-vaccine-risk-benefit-monitoring-in-europe.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Typhoid Journal: How is the Pathogenesis of Typhoid Fever</title>
		<link>http://d02now.com/internal/typhoid-fever/typhoid-journal-how-is-the-pathogenesis-of-typhoid-fever.html</link>
		<comments>http://d02now.com/internal/typhoid-fever/typhoid-journal-how-is-the-pathogenesis-of-typhoid-fever.html#comments</comments>
		<pubDate>Sun, 15 Nov 2009 19:35:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Typhoid Fever]]></category>
		<category><![CDATA[Salmonella]]></category>
		<category><![CDATA[Typhoid article]]></category>
		<category><![CDATA[Typhoid Journal]]></category>
		<category><![CDATA[Typhoid pathogenesis]]></category>

		<guid isPermaLink="false">http://d02now.com/internal/typhoid-fever/typhoid-journal-how-is-the-pathogenesis-of-typhoid-fever.html</guid>
		<description><![CDATA[The pathogenesis of typhoid fever in association with the adherence to and invasion of gut epithelial cells,  dissemination to systemic sites, and survival and replication within host cells are three areas which are outlined in the following typhoid journal.]]></description>
		<wfw:commentRss>http://d02now.com/internal/typhoid-fever/typhoid-journal-how-is-the-pathogenesis-of-typhoid-fever.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Qs And As Article about Oseltamivir Phosphate Medication</title>
		<link>http://d02now.com/internal/qs-and-as-article-about-oseltamivir-phosphate-medication.html</link>
		<comments>http://d02now.com/internal/qs-and-as-article-about-oseltamivir-phosphate-medication.html#comments</comments>
		<pubDate>Sun, 15 Nov 2009 19:03:43 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Oseltamivir]]></category>
		<category><![CDATA[Oseltamivir Phosphate]]></category>
		<category><![CDATA[Tamiflu]]></category>

		<guid isPermaLink="false">http://d02now.com/internal/qs-and-as-article-about-oseltamivir-phosphate-medication.html</guid>
		<description><![CDATA[Oseltamivir phosphate or known as TAMIFLU® is one of FDA-approved to treat and prevent influenza. Question and  Answers regarding oseltamivir phosphate antiviral medication is covered in the following article.]]></description>
		<wfw:commentRss>http://d02now.com/internal/qs-and-as-article-about-oseltamivir-phosphate-medication.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>H1N1 Article: Clinical Management Protocol for Swine Influenza</title>
		<link>http://d02now.com/internal/animal-born-disease/swine-flu/h1n1-article-clinical-management-protocol-for-swine-influenza.html</link>
		<comments>http://d02now.com/internal/animal-born-disease/swine-flu/h1n1-article-clinical-management-protocol-for-swine-influenza.html#comments</comments>
		<pubDate>Sat, 07 Nov 2009 06:51:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Swine Flu]]></category>
		<category><![CDATA[management guideline]]></category>
		<category><![CDATA[perating procedures]]></category>
		<category><![CDATA[Swine Flu Protocol]]></category>

		<guid isPermaLink="false">http://d02now.com/internal/animal-born-disease/swine-flu/h1n1-article-clinical-management-protocol-for-swine-influenza.html</guid>
		<description><![CDATA[Herein is an article dicussed Clinical Management Protocol for H1N1 Influenza A (Swine Flu) Virus. There are section discussed : clinical management protocol, Guidelines on Infection Control Measures, operating procedures for infection control practices.]]></description>
		<wfw:commentRss>http://d02now.com/internal/animal-born-disease/swine-flu/h1n1-article-clinical-management-protocol-for-swine-influenza.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>2008 Anemia Journal: Hidroxyurea and Sickle Cell Anemia</title>
		<link>http://d02now.com/internal/anemia/2008-anemia-journal-hidroxyurea-and-sickle-cell-anemia.html</link>
		<comments>http://d02now.com/internal/anemia/2008-anemia-journal-hidroxyurea-and-sickle-cell-anemia.html#comments</comments>
		<pubDate>Wed, 28 Oct 2009 19:36:58 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[anemia]]></category>
		<category><![CDATA[Sickle Cell]]></category>
		<category><![CDATA[Hydroxyurea]]></category>
		<category><![CDATA[Sickle Cell Anemia]]></category>

		<guid isPermaLink="false">http://d02now.com/internal/anemia/2008-anemia-journal-hidroxyurea-and-sickle-cell-anemia.html</guid>
		<description><![CDATA[The Journal covers clinical therapeutics of Sickle Cell Anemia regarding hydroxyurea' treatment sections such the Clinical Problem, Pathophysiology and Effect of Therapy (click picture to enlarge), Clinical evidence, Hydroxyurea Clinical Use, Adverse Effects of Hydroxyurea, Peripheral-Blood Thresholds for Adjustment of the Dose of Hydroxyurea, and Areas of Uncertainty in the Hydroxyurea treatment.]]></description>
		<wfw:commentRss>http://d02now.com/internal/anemia/2008-anemia-journal-hidroxyurea-and-sickle-cell-anemia.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Rheumatology Article: Pathophysiology of Fibromyalgia</title>
		<link>http://d02now.com/internal/rheumatology-article-pathophysiology-of-fibromyalgia.html</link>
		<comments>http://d02now.com/internal/rheumatology-article-pathophysiology-of-fibromyalgia.html#comments</comments>
		<pubDate>Tue, 20 Oct 2009 14:50:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[fibromyalgia]]></category>
		<category><![CDATA[pathophysiology of fibromyalgia]]></category>

		<guid isPermaLink="false">http://d02now.com/internal/rheumatology-article-pathophysiology-of-fibromyalgia.html</guid>
		<description><![CDATA[This is a diagram of proposed interactions of various muscle abnormalities to pain and muscle dysfunction in fibromyalgia. It was hypothesized that any condition that could lead to constant muscle hypoxia and prolonged energy deficiency might be a cause of fibromyalgic pain. If you need to complete the pathophysiology of myalgia, you can download it [...]]]></description>
		<wfw:commentRss>http://d02now.com/internal/rheumatology-article-pathophysiology-of-fibromyalgia.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Use of JNC 7 Express Hypertension Guidelines for Primary Care</title>
		<link>http://d02now.com/internal/hypertension-internal/the-use-of-jnc-7-express-hypertension-guidelines-for-primary-care.html</link>
		<comments>http://d02now.com/internal/hypertension-internal/the-use-of-jnc-7-express-hypertension-guidelines-for-primary-care.html#comments</comments>
		<pubDate>Sun, 11 Oct 2009 08:41:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Hypertension]]></category>
		<category><![CDATA[Express]]></category>
		<category><![CDATA[guideline]]></category>
		<category><![CDATA[JNC 7]]></category>

		<guid isPermaLink="false">http://d02now.com/internal/hypertension-internal/the-use-of-jnc-7-express-hypertension-guidelines-for-primary-care.html</guid>
		<description><![CDATA[Here we serve you with information regarding guidelines for hypertension in association with the prevention, detection, evaluation and the treatment of high blood pressure for primary care.]]></description>
		<wfw:commentRss>http://d02now.com/internal/hypertension-internal/the-use-of-jnc-7-express-hypertension-guidelines-for-primary-care.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Swine Flu Antiviral Medication for High-Risk Group</title>
		<link>http://d02now.com/internal/animal-born-disease/swine-flu/swine-flu-antiviral-medication-for-high-risk-group.html</link>
		<comments>http://d02now.com/internal/animal-born-disease/swine-flu/swine-flu-antiviral-medication-for-high-risk-group.html#comments</comments>
		<pubDate>Sun, 06 Sep 2009 05:43:31 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Swine Flu]]></category>
		<category><![CDATA[flu high risk]]></category>
		<category><![CDATA[swine flu medication]]></category>

		<guid isPermaLink="false">http://d02now.com/internal/animal-born-disease/swine-flu/swine-flu-antiviral-medication-for-high-risk-group.html</guid>
		<description><![CDATA[Antiviral treatment and chemoprophylaxis efforts of influenza A (H1N1)-Swine Flu are recommended primarily at persons who are hospitalizad or at high risk for influenza complications. And the following article will give description about Swine Flu Antiviral Medication for these High-Risk Groups.]]></description>
		<wfw:commentRss>http://d02now.com/internal/animal-born-disease/swine-flu/swine-flu-antiviral-medication-for-high-risk-group.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

